Literature DB >> 13690224

Muscle weakness caused by bretylium tosylate.

E D CAMPBELL, E MONTUSCHI.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS/toxicology; MUSCLES/pharmacology; SYMPATHOLYTICS/toxicology

Mesh：

Substances：

Year:  1960        PMID： 13690224     DOI： 10.1016/s0140-6736(60)91857-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Bretylium tosylate in treatment of severe hypertension.

Authors:  K SOMERS
Journal:  Br Med J       Date:  1962-03-31

2.  Circulatory and respiratory effects of guanethidin.

Authors:  R ROKSETH; O STORSTEIN; A VOLL; A M ABRAHAMSEN; J OFSTAD
Journal:  Br Heart J       Date:  1962-03

3.  The discovery of bretylium and bethanidine.

Authors:  A F Green
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

4.  Effects of some polymethylene bis(hydroxyethyl)dimethylammonium salts on neuromuscular transmission.

Authors:  W C Bowman; B A Hemsworth
Journal:  Br J Pharmacol Chemother       Date:  1965-10

5.  Action of bretylium and guanethidine at the neuromuscular junction.

Authors:  B N DIXIT; O D GULATI; S D GOKHALE
Journal:  Br J Pharmacol Chemother       Date:  1961-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.